Federated Hermes’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-87,425
Closed -$283K 2171
2024
Q3
$283K Sell
87,425
-8,585
-9% -$27.8K ﹤0.01% 1432
2024
Q2
$288K Hold
96,010
﹤0.01% 1421
2024
Q1
$446K Sell
96,010
-3,829
-4% -$17.8K ﹤0.01% 1351
2023
Q4
$413K Sell
99,839
-14,363
-13% -$59.5K ﹤0.01% 1388
2023
Q3
$343K Buy
114,202
+78
+0.1% +$234 ﹤0.01% 1436
2023
Q2
$281K Buy
+114,124
New +$281K ﹤0.01% 1508